Atherothrombotic events and clopidogrel therapy [2]
10.1503/cmaj.1060153
Saved in:
Main Authors: | McLachlan, C.S., Tay, S.K.H., Almsherqi, Z., Chia, S.-H. |
---|---|
Other Authors: | PHYSIOLOGY |
Format: | Others |
Published: |
2014
|
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/107464 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Evaluation of clopidogrel resistance [3]
by: Almsherqi, Z.A., et al.
Published: (2011) -
Can clopidogrel monotherapy influence vascular remodeling? [1]
by: Hui, C.S., et al.
Published: (2014) -
Optimal antiplatelet treatment for percutaneous coronary intervention: Clopidogrel vs. ticlopidine
by: Almsherqi, Z.A., et al.
Published: (2011) -
Optimal antiplatelet treatment for percutaneous coronary intervention: Clopidogrel vs. ticlopidine
by: Almsherqi, Z.A., et al.
Published: (2016) -
CYP2C19 polymorphisms in the Thai population and the clinical response to clopidogrel in patients with atherothrombotic-risk factors
by: Chonlaphat Sukasem, et al.
Published: (2018)